Lista de obras -

1H, 13C and 15N NMR data for indolo[2,3-b]quinolines, a novel potent anticancer drug family.

artículo científico publicado en 2013

A derivative of 5-H-indolo[2,3-b]quinoline--a novel liposomally-formulated anticancer agent

scientific article published on 01 January 2002

A solution and solid state 15N NMR study of hydrogen bonding in a Schiffs base

artículo científico publicado en 1996

An efficient synthesis of indolo[2,3-b]quinoline guanidine derivatives with their in vitro and in vivo study

artículo científico publicado en 2017

Apoptotic effect of imatinib on human colon adenocarcinoma cells: Influence on actin cytoskeleton organization and cell migration ⬇️

artículo científico publicado el 30 de mayo de 2011

Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against Plasmodium falciparum

artículo científico publicado en 2020

Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.

artículo científico publicado en 2005

Complex formation in the indolo[2,3-b]quinolines--methylene blue systems in aqueous solutions.

artículo científico publicado en 2001

Identification and characterization of potential impurities of quetiapine fumarate.

artículo científico publicado en 2009

Identification and physicochemical characteristics of temozolomide process-related impurities.

artículo científico publicado en 2013

Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin.

artículo científico publicado en 2016

Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b]quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells

artículo científico publicado en 2008

Membrane perturbations induced by new analogs of neocryptolepine

artículo científico publicado en 2012

New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.

artículo científico publicado en 2012

Optimization of aripiprazole synthesis

artículo científico publicado en 2010

SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.

artículo científico publicado en 2016

Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.

artículo científico publicado en 2014

Sequence-selectivity of 5,11-dimethyl-5H-indolo[2,3-b]quinoline binding to DNA. Footprinting and molecular modeling studies.

artículo científico publicado en 2000

Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.

artículo científico publicado en 2012

Synthesis of 6-substituted 6H-indolo[2,3-b]quinolines as novel cytotoxic agents and topoisomerase II inhibitors.

artículo científico publicado en 2002

Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors

scientific article published on 01 November 1999

The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents

artículo científico publicado en 2015

Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development

artículo científico publicado en 2017

Lista de obras de

1H, 13C and 15N NMR data for indolo[2,3-b]quinolines, a novel potent anticancer drug family.

A derivative of 5-H-indolo[2,3-b]quinoline--a novel liposomally-formulated anticancer agent

A solution and solid state 15N NMR study of hydrogen bonding in a Schiffs base

An efficient synthesis of indolo[2,3-b]quinoline guanidine derivatives with their in vitro and in vivo study

Apoptotic effect of imatinib on human colon adenocarcinoma cells: Influence on actin cytoskeleton organization and cell migration ⬇️

Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against Plasmodium falciparum

Biological evaluation of omega-(dialkylamino)alkyl derivatives of 6H-indolo[2,3-b]quinoline--novel cytotoxic DNA topoisomerase II inhibitors.

Complex formation in the indolo[2,3-b]quinolines--methylene blue systems in aqueous solutions.

Identification and characterization of potential impurities of quetiapine fumarate.

Identification and physicochemical characteristics of temozolomide process-related impurities.

Imatinib Inhibits the Renewal and Tumorigenicity of CT-26 Colon Cancer Cells after Cytoreductive Treatment with Doxorubicin.

Liposomal formulation of DIMIQ, potential antitumor indolo[2,3-b]quinoline agent and its cytotoxicity on hepatoma Morris 5123 cells

Membrane perturbations induced by new analogs of neocryptolepine

New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.

Optimization of aripiprazole synthesis

SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.

Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.

Sequence-selectivity of 5,11-dimethyl-5H-indolo[2,3-b]quinoline binding to DNA. Footprinting and molecular modeling studies.

Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.

Synthesis of 6-substituted 6H-indolo[2,3-b]quinolines as novel cytotoxic agents and topoisomerase II inhibitors.

Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors

The synthesis of indolo[2,3-b]quinoline derivatives with a guanidine group: highly selective cytotoxic agents

Use of the hyphenated LC-MS/MS technique and NMR/IR spectroscopy for the identification of exemestane stress degradation products during the drug development